Milestones

 
2001
2002
  • First cord blood released for sibling-use
  • Laboratory at Camden Medical Centre opened for public viewing
2003
  • Acquired Cytomatrix, a stem cell research company specialising in cell expansion technology.
2004
  • First and only cord blood bank in Southeast Asia to be listed on the Australian Securities Exchange (ASX).
  • Became a founding member of the Asia Pacific Cord Blood Banks Consortium (APCBBC).
  • Established marketing offices in Indonesia and Thailand.
2005
  • Received accreditation from American Association of Blood Banks (AABB)

    AABB's Accreditation Program strives to improve the quality and safety of collecting, processing, testing, distributing and administering blood and blood products by assessing the quality and operational systems in place within the facility.

  • Offered Medicord, a stem cell transplant insurance programme
  • Entered Hong Kong and People's Republic of China (PRC) markets
  • Successfully acquired Biocell, the second largest private cord blood bank in Australia.
  • Marketing office established in Philippines.
2006
  • Incorporated Cordlife Sciences India Pvt. Ltd., which was officially launched by Singapore Senior Minister and former Prime Minister Mr Goh Chok Tong in Kolkata.
  • Sponsored the first cystic fibrosis cord blood collection in Australia.
  • Acquired 20 percent of Netherlands tissue engineering company, PharmaCell BV
2007
  • Globally recognised as “Technology Pioneer” by the World Economic Forum.
  • Launched the first and only DEPKES licensed cord blood processing and storage facility in Indonesia through a joint venture partnership with the country’s largest pharmaceutical company, Kalbe Farma.
  • Expanded to new Science Park II facility
  • Cordlife Hong Kong achieved ISO:9001
  • Launched the first and only DEPKES licensed cord blood processing and storage facility in Indonesia through a joint venture partnership with the country’s largest pharmaceutical company, Kalbe Farma.
2008
  • Re-accredited by American Association of Blood Banks (AABB)
  • Launch of automated processing system, Sepax®, to maximise recovery of cells for transplant use
  • Launched “Cordlife Cares” programme, the first corporate social responsibility of its kind in Singapore, which offers free private cord blood banking to families in need.
  • Another Cordlife sales office opened in Medan, Indonesia’s third largest city.
  • A second office in Hong Kong opened in Kowloon, strategically opposite Hong Kong Baptist Hospital which holds the record for the country’s highest number of private deliveries.
2009
  • Re-accredited by American Association of Blood Banks (AABB)
  • First-ever release of autologous cord blood for Cerebral Palsy
  • India’s largest and most advanced facility opened, the first and only private cord blood bank in West Bengal. This fourth overseas facility is also the Group’s biggest thus far.
  • BioCell merged with CellSense and was rebranded as “Australian Stem Cell Healthcare”, the largest private cord blood bank in Australia.
  • Cordlife Hong Kong successfully certified by ISO for the second time.
  • Cordlife India received ISO certification for its quality management system.
  • Opened first and only cord blood processing and cryopreservation facility registered with the Department of Health in Manila at UP-AyalaLand Technohub.
  • Appointed as Quality Advisor to Beijing Cord Blood Bank, one of the largest cord blood banks in China.
  • Launched Cordlife Quality Guarantee, a warranty to protect Cordlife clients
  • Launched Cordlife Circle, a members-only benefit programme
  • Launched Preferential Plan upgrades for clients
2010
  • First-ever release of autologous cord blood for Neuroblastoma
  • First in the Philippines to incorporate Sepax, a fully automated system for cord blood processing.
  • Group CEO, Dr Steven Fang, honored as the Most Outstanding Entrepreneur by APEA.
  • Released autologous cord blood for Cerebral Palsy
  • First in India to introduce umbilical cord blood service for the cryopreservation of two cell lines.
  • Secured strategic stake in China Stem Cells (South) Company Limited with US$10 million investment.
  • Cordlife Indonesia received ISO 9001:2008 certification.
  • Celebrated enrolment of our 25,000th client
  • Celebrated 10 years of quality cord blood banking
2011
  • CordLife Pte Ltd renamed to "Cordlife Group Limited"
  • Launched Cordlife Care360° Safeguard programme
  • Re-accredited by American Association of Blood Banks (AABB)
  • Launched provision of umbilical cord tissue banking services in Hong Kong
  • Hong Kong facility accredited by American Association of Blood Banks (AABB)
  • Released cord blood unit for the first autologous treatment of neuroblastoma in Hong Kong.
  • Released cord blood unit for the first sibling-related treatment of thalassaemia major in West Bengal.
  • Demerger1 of Cordlife Singapore, Hong Kong and strategic interest in China from Cordlife Limited.
1Cordlife Group Limited and Cordlife Limited are separate and independent companies. Both companies are affiliated through contractual agreements for the fulfillment of cross-border customer requests. The Cordlife brand and www.Cordlife.com are properties of Cordlife Group Limited.

2012
2013
  • Cordlife Group Limited moved to its fully owned, 23,000sqft office and laboratory facility in A'Posh Bizhub, Yishun. The facility is capable of storing up to 650,000 cord blood units.
  • First private cord blood bank in Singapore to launch automated processing system, Sepax®2, to facilitate the optimisation of cord blood stem cells for maximum transplant successˆ.
  • Re-accredited by American Association of Blood Banks (AABB)
  • Launched provision of umbilical cord lining banking services in Singapore with patented technology, CellOptima™ that is exclusively available at Cordlife capable of isolating EpSCs and MSCs, two types of stem cells present in the umbilical cord.
  • Awarded 'Most Transparent Company Award' by SIAS Investors Choice
2014
  • Processed and stored over 45,000 cord blood units as of 21 March 2014
  • Collaborated with Make-A-Wish Foundation® (Singapore) Ltd – granting the wishes of children with life-threatening medical conditions to enrich the human experience with hope, strength and joy.
  • Enhanced Cordlife Pledge:360˚ assures quality processing and storage standards

 

ˆConditions apply.